Related Experiment Videos
Biologic response modifiers in the therapy of metastatic renal cell carcinoma
1Department of Clinical Immunology and Biology Therapy, University of Texas M.D. Anderson Hospital and Tumor Institute, Houston 77030.
Seminars in Oncology
|August 1, 1988
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Durable complete remissions after 2'-deoxycoformycin treatment in patients with hairy cell leukemia resistant to interferon alpha.
American journal of hematology·1990
Biologic response modifiers in cancer therapy: a review.
Texas medicine·1989
Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia.
American journal of hematology·1988
Recombinant interferon alpha and gamma in combination as treatment for metastatic renal cell carcinoma.
Journal of biological response modifiers·1988
Phase I study of recombinant methionyl human consensus interferon (r-metHuIFN-Con1).
Journal of biological response modifiers·1988
The role of fumarate and itaconate in tumor microenvironment.
Seminars in oncology·2026
Spatiotemporal decoding of the pre-metastatic niche: Multi-omics innovations and clinical horizons.
Seminars in oncology·2026
Receptor Co‑targeting Strategies for Personalized Ovarian Cancer Therapy.
International journal of nanomedicine·2026
A germline KDM3C polymorphism impairs DNA repair and sensitizes to chemoradiotherapy.
medRxiv : the preprint server for health sciences·2026
Protective Effect of Sodium-Glucose Cotransporter 2 Inhibitors (SGLT2i) on Liver Function: Results From MELD Analysis in Surgical Revascularization-A Preliminary Study.
Medical science monitor : international medical journal of experimental and clinical research·2026